u/Giganticturd

I've been digging deeper into the latest PyroGenesis fumed-silica update, and I think the market is still looking at this completely wrong.

Everyone is focused on:

"It's a 1,000 tonne/year reactor."

That's not the story.

The story is what happens if the first commercial reactor proves the economics and becomes a repeatable plant platform.

And when you compare the potential economics to the current market caps of both HPQ Silicon and PyroGenesis, the asymmetry gets pretty crazy.

FIRST: WHAT EXACTLY IS FUMED SILICA?

Fumed silica — also called pyrogenic silica — is an ultra-fine, high-surface-area form of silicon dioxide.

It isn't commodity sand.

It is a specialty material used as a thickener, stabilizer, anti-caking agent and performance additive across thousands of products.

Applications include:

Adhesives

Sealants

Paints

Coatings

Construction

Pharmaceuticals

Cosmetics

Food

Agriculture

Automotive

Batteries

Personal care

HPQ/PyroGenesis is attempting to produce it directly from quartz using the Fumed Silica Reactor (FSR) in a single plasma-based process.

PyroGenesis says the technology eliminates harmful chemicals used in conventional production. (PyroGenesis Inc.)

THE MARKET IS BILLIONS OF DOLLARS

HPQ/PyroGenesis previously cited a global fumed silica market of approximately US$1.3B in 2022, growing toward roughly US$2.1B by 2032. (PyroGenesis Inc.)

More recent industry estimates put the market even higher.

HPQ itself currently references a global opportunity that could reach billions of dollars, while another recent HPQ presentation discusses the fumed silica market reaching approximately US$2.57B by 2034. (HPQ Silicon)

So we're talking about a multi-billion-dollar specialty-material market.

And the first commercial FSR is only:

1,000 tonnes/year.

That's tiny relative to the total market.

NOW LOOK AT THE CAPEX

This is where the story gets REALLY interesting.

PyroGenesis/HPQ's earlier economic analysis estimated capital intensity of approximately:

Conventional process: ~US$145.92/kg of annual capacity

versus approximately:

FSR process: ~US$9–10/kg of annual capacity

That's potentially a ~93% reduction in capital intensity.

The current commercial proposal is for a 1,000 TPY FSR reactor priced at US$20M. (PyroGenesis Inc.)

And here's an important point:

The first commercial reactor isn't necessarily being funded by HPQ shareholders.

Under the proposed JV structure, the strategic partner is expected to finance the US$20M reactor.

That's potentially a huge advantage.

WHAT DOES A LEGACY PLANT COST?

Look at the conventional industry.

PyroGenesis has previously referenced a Wacker US fumed-silica facility costing approximately US$150M for 20,000 tonnes/year.

That's about:

US$7,500 per annual tonne of capacity.

But that's just one comparison and isn't perfectly apples-to-apples because conventional production involves upstream infrastructure and different process configurations.

The more important number is the company's modeled total process capital intensity:

~$145.92/kg conventional

versus

~$9–10/kg FSR.

If those economics survive commercial-scale operation, that's potentially a massive competitive advantage.

AND THEN WE GET TO EBITDA

The earlier economic study estimated:

60–65% EBITDA margins

and approximately:

1.7-year payback

for the 1,000 TPY FSR model.

Let's use a conservative illustrative example of $7M EBITDA per plant.

Then:

1 plant

~$7M EBITDA

5 plants

~$35M

10 plants

~$70M

25 plants

~$175M

50 plants

~$350M

100 plants

~$700M

Obviously, these are scenario calculations, NOT forecasts.

But this is exactly how I think investors should be looking at the technology.

The first reactor isn't the end game.

It's the factory template.

NOW LOOK AT HPQ

This is where I think the valuation gets particularly interesting.

HPQ Silicon currently has approximately:

471.4M shares outstanding

and a market cap of approximately:

C$68.4 MILLION

at around C$0.145/share. (TMX Money)

Read that again.

C$68M market cap.

For a company developing a technology that could potentially participate in a multi-billion-dollar fumed-silica market.

And fumed silica isn't even HPQ's only technology.

HPQ also has:

High-purity silicon

Silicon-based battery materials

Novacium

Hydrogen technology

HPQ's own investor materials identify multiple technology platforms and show approximately 471M shares outstanding. (HPQ Silicon)

NOW THE VALUATION MATH

Let's completely ignore the other HPQ businesses for a minute.

Imagine the FSR business eventually produces economic value equivalent to:

$10M EBITDA

At 10x EBITDA:

$100M valuation

At 15x:

$150M

$25M EBITDA

10x:

$250M

15x:

$375M

$50M EBITDA

10x:

$500M

15x:

$750M

$100M EBITDA

10x:

$1 BILLION

15x:

$1.5 BILLION

And HPQ is currently around:

C$68M market cap.

That's the asymmetry.

WHAT WOULD THAT MEAN FOR HPQ'S SHARE PRICE?

Using the current ~471.4M shares purely for illustration:

HPQ Market Cap

Approx. HPQ Share Price

C$68M

~$0.145

C$100M

~$0.21

C$250M

~$0.53

C$375M

~$0.80

C$500M

~$1.06

C$750M

~$1.59

C$1B

~$2.12

C$1.5B

~$3.18

Again:

These aren't price targets.

They're simply market-cap math using today's approximate share count.

Dilution could obviously change these numbers.

But going from:

C$68M → C$500M

would represent roughly a:

7.3X increase in equity value.

C$68M → C$1B would be roughly:

14.6X.

And that's BEFORE assigning meaningful value to HPQ's battery-material, high-purity silicon and hydrogen opportunities.

AND PYROGENESIS ISN'T JUST THE CONTRACTOR

This is another piece I think gets overlooked.

PyroGenesis exercised its option to convert its royalty rights into 50% ownership of HPQ Silica Polvere. (PyroGenesis Inc.)

That means PYR potentially participates directly in the economics of the FSR business.

So you have a potentially very interesting structure:

HPQ → owns the FSR business / Polvere

PYR → owns 50% of Polvere

PYR → designs/builds the commercial FSR

Strategic partner → potentially finances the first $20M reactor

If this scales, there are multiple ways value can accrue.

THIS IS WHERE A BIDDING WAR COULD HAPPEN

I'm NOT saying there is currently a confirmed bidding war.

But imagine this scenario:

The first 1,000 TPY reactor is built.

It runs.

Independent customers qualify the material.

The economics are validated.

And suddenly a large manufacturer says:

"We want our own plant."

Then another says:

"We want one too."

Then another.

At that point, the FSR isn't just an interesting technology.

It becomes scarce production capacity.

And when a technology potentially offers dramatically lower capital intensity than incumbent processes, customers don't necessarily want to wait years for someone else to build capacity.

That's where you could potentially see:

multiple strategic partners competing for access to the technology.

Again, that's the bull-case scenario—not something that has been announced as fact.

AND THERE IS ALREADY COMMERCIAL VALIDATION

This isn't just a PowerPoint.

HPQ has already reported:

✓ Pilot-scale production

✓ Independent laboratory testing

✓ Material meeting fundamental commercial specifications

✓ A 50 kg purchase order for advanced customer testing

✓ Extended semi-continuous FSR production runs

✓ Engineering data being generated for the 1,000 TPY commercial facility

The 50 kg order came from the strategic industrial partner and was produced using PyroGenesis' FSR pilot plant. (HPQ Silicon)

PyroGenesis also announced successful independent third-party testing of FSR-produced material in February 2026. (PyroGenesis Inc.)

That's a meaningful progression from:

technology → pilot → validation → customer testing → commercial reactor.

NOW LOOK AT THE TWO MARKET CAPS TOGETHER

This is what gets me excited.

HPQ:

~C$68M

PyroGenesis:

small-cap company with a market value nowhere near the potential value of a successful global deployment platform.

And the first commercial reactor:

US$20M.

The underlying market:

multi-billion dollars.

Potential economics:

60–65% EBITDA in the company's earlier model.

Potential payback:

~1.7 years in that model.

Potential deployment:

not one reactor — potentially dozens or hundreds if the technology works commercially.

THE REAL BULL CASE

The bull case isn't:

"PYR sells a $20M reactor."

That's boring.

The bull case is:

1,000 TPY reactor

↓

commercial validation

↓

customer qualification

↓

second reactor

↓

multiple customers

↓

repeatable deployment

↓

JV/royalty/ownership economics

↓

dozens of reactors

↓

potentially hundreds of reactors

↓

a new decentralized fumed-silica production model

That's when the valuation starts getting interesting.

WHAT IF HPQ ONLY CAPTURES A SMALL PIECE?

Let's say the global market is ~$2B+.

If the FSR eventually enabled HPQ/its partners to capture only:

5% of the market

That's roughly:

$100M of annual fumed-silica revenue.

10%:

$200M

20%:

$400M

These aren't forecasts.

They're simply showing how little market share is required before the opportunity becomes enormous relative to a C$68M company.

And because the FSR potentially changes the cost structure, the important metric isn't just revenue.

It's EBITDA and free cash flow.

WHAT I'M WATCHING NOW

The next major catalysts are pretty obvious:

1. Definitive JV agreement

2. Final commercial reactor order

3. Construction

4. Customer qualification

5. First commercial production

6. Proof of the projected economics

7. Additional reactor orders

8. Additional strategic partners

If those start hitting one after another, the market may have no choice but to start valuing HPQ and PYR on future FSR economics rather than today's tiny revenue base.

MY TAKE

At ~C$68M, HPQ doesn't need to dominate the global fumed silica market.

It doesn't even need 20%.

It needs the technology to work.

If a ~$20M commercial reactor can prove the economics, and that reactor becomes the template for additional plants, the potential EBITDA generated by a scaled network could be orders of magnitude larger than HPQ's current market capitalization.

And because PYR owns 50% of HPQ Silica Polvere, PYR has direct exposure too. (PyroGenesis Inc.)

That's why today's announcement gets my attention.

The first reactor isn't the prize.

The first reactor is the proof that the next 10, 50 or 100 reactors are possible.

And if the economics actually work at scale?

The market caps we're looking at today could eventually look very, very small.

🚀

Bullish? Absolutely.

Guaranteed? Absolutely not.

This is still a speculative commercialization story, and the MOU, customer qualification, scale-up, economics and future financing all carry risk.

But IMO the risk/reward gets extremely interesting when you compare:

C$68M HPQ market cap

against

a multi-billion-dollar target market

and a technology potentially capable of dramatically reducing the capital intensity of entering it.

That's the FSR thesis.

Before investing in HPQ, investors should understand one thing:

Fumed silica is not some niche laboratory material.

It is one of the most widely used industrial materials in the world and is found in thousands of products including cosmetics, toothpaste, pharmaceuticals, batteries, paints, adhesives, sealants, food products, construction materials, thermal insulation and electronics.

It is a critical performance ingredient used across multiple global industries.

The global fumed silica market is estimated at approximately US$1.8 billion today and projected to exceed US$2 billion by the end of the decade.

Now ask yourself:

How many junior resource and technology companies are targeting a market of that size with a potentially disruptive manufacturing process?

Very few.

That’s why I believe HPQ may be one of the most misunderstood stories on the TSXV.

For years, investors questioned whether the Fumed Silica Reactor (FSR) could actually work.

Today, that conversation is changing.

Commercial-grade material has been independently verified.

A strategic industrial partner has emerged.

A commercial 1,000 tonne-per-year plant has been proposed.

The partner has reportedly secured project financing.

The first purchase order has already been received for advanced qualification testing.

The next major catalyst?

According to PyroGenesis, the definitive agreements associated with the commercial joint venture are expected to be completed by the end of Q2 2026.

That means investors are potentially weeks away from learning whether HPQ’s commercialization strategy takes a major step forward.

But here’s what I think the market is completely missing.

The Real Story Isn’t the Technology. It’s the Economics.

Most investors are asking:

“Can HPQ make fumed silica?”

The better question may be:

“Can HPQ make it significantly cheaper and more profitably than the existing industry?”

According to economic studies previously disclosed by HPQ and PyroGenesis, the FSR process could potentially generate EBITDA margins in the 60-65% range, compared to approximately 20% industry averages cited in the study.

Even more remarkable, the studies suggested capital costs could be dramatically lower than conventional production methods because the FSR aims to produce fumed silica directly from quartz in a simplified process rather than relying on multiple traditional production stages.

If those economics ultimately prove accurate at commercial scale, HPQ would not simply be competing against incumbent producers.

It would be competing against their entire cost structure.

Think about that.

Higher margins.

Lower capital intensity.

Potentially lower environmental footprint.

Potentially simpler production.

That combination is what creates disruptive technologies.

The First Plant Isn’t the Opportunity

The first plant is the proof.

In the commercial plant announcement, PyroGenesis explicitly stated there is expected to be a need for a series of additional fumed silica plants of the same or larger size.

A series.

Not one.

A series.

Management has repeatedly discussed creating a commercial model that can be replicated as demand grows.

That’s the part of the story that gets me excited.

One plant proves the technology.

Several plants prove the business model.

A network of plants creates an industrial platform.

And once the first plant is operating successfully, future partners may not need to take technology risk anymore because commercial-scale validation will already exist.

That is how small companies become large companies.

Why Q2 Matters

The market currently appears to value HPQ largely as a development-stage company.

The upcoming Q2 milestone could begin changing that perception.

If definitive agreements are signed and commercialization advances as expected, investors may start viewing HPQ differently:

Not as a technology experiment.

Not as a pilot project.

But as the owner of a potentially disruptive industrial manufacturing platform targeting a multi-billion-dollar market.

The next few weeks could be among the most important in the company’s history.